search
mechan
underli
autoimmun
autism
postul
gliadin
peptid
heat
shock
protein
streptokinas
sk
bind
differ
peptidas
result
autoantibodi
product
compon
assess
hypothesi
patient
autism
mix
connect
tissu
diseas
associ
antigliadin
antihsp
antibodi
children
autism
patient
autoimmun
diseas
develop
antidipeptidylpeptidas
dpp
antidipeptidylpeptidas
iv
dpp
iv
antiaminopeptidas
n
autoantibodi
signific
percentag
autoimmun
autist
sera
associ
elev
immunoglobulin
g
igg
igm
iga
antibodi
three
peptidas
gliadin
antibodi
specif
sinc
immun
absorpt
demonstr
specif
antigen
eg
dpp
iv
absorpt
antidpp
iv
significantli
reduc
igg
igm
iga
antibodi
level
direct
demonstr
sk
gliadin
peptid
bind
dpp
iv
microtit
well
coat
dpp
iv
react
sk
gliadin
react
antidpp
iv
antisk
antihsp
antigliadin
antibodi
ad
sk
gliadin
peptid
dpp
iv
result
inhibit
dpp
ivantidpp
iv
reaction
dpp
ivposit
peptid
caus
enhanc
antigenantibodi
reaction
propos
superantigen
eg
sk
dietari
protein
eg
gliadin
peptid
individu
predispos
hla
molecul
bind
aminopeptidas
ii
induc
autoantibodi
peptid
tissu
antigen
dysfunct
membran
peptidas
autoantibodi
product
may
result
neuroimmun
dysregul
autoimmun
autism
development
disord
unknown
etiolog
sever
factor
implic
pathogenesi
includ
genet
environment
immunolog
neurolog
element
immun
abnorm
autism
includ
chang
number
activ
macrophag
cell
b
cell
natur
killer
cell
activ
addit
shift
occur
helper
helper
cell
autism
evidenc
decreas
product
gamma
interferon
increas
product
anoth
studi
report
innat
adapt
immun
respons
children
autism
associ
tumor
necrosi
factor
alpha
andor
valu
standard
deviat
sd
control
mean
better
understand
possibl
origin
autoimmun
mechan
theori
propos
investig
underli
caus
autism
immunogenet
analys
reveal
gene
long
implic
lupu
arthriti
significantli
increas
autist
popul
frequenc
complement
allel
gene
increas
autist
individu
unusu
high
rate
autoimmun
disord
famili
autist
child
largerscal
analys
reveal
famili
autist
children
occurr
autoimmun
diseas
firstand
seconddegre
rel
gener
increas
preval
autoimmun
diseas
famili
member
common
among
proband
autoimmun
disord
increas
famili
autoimmun
diseas
autist
proband
verifi
addit
research
immunolog
contribut
pathophysiolog
autism
would
seem
warrant
membran
peptidas
immun
system
cell
surfac
peptidas
aminopeptidas
n
aminopeptidas
dipeptidylpeptidas
dpp
dipeptidylpeptidas
iv
dpp
iv
play
key
role
growth
differenti
lymphocyt
leukemia
lymphoma
cell
cleav
peptid
mediat
result
activ
inactiv
function
receptor
well
signal
transduct
adhes
molecul
express
stem
cell
development
stage
myeloid
cell
earliest
stage
differenti
b
cell
becom
neg
matur
intestin
brush
border
protein
involv
termin
degrad
small
peptid
amino
acid
scaveng
inactiv
endorphin
enkephalin
synapt
membran
nervou
system
also
major
receptor
transmiss
viru
caus
sever
gastroenter
piglet
coronaviru
caus
upper
respiratori
infect
human
dpp
cystein
proteas
found
lung
myelomonocyt
cell
cytotox
cell
mast
cell
dpp
appar
special
produc
peptid
present
class
major
histocompat
complex
molecul
particip
antigen
present
dpp
iv
close
relat
famili
glycoprotein
express
cell
surfac
plasma
membran
local
epitheli
brush
border
membran
intestin
mucosa
cleav
xpro
dipeptid
nh
terminu
sever
protein
due
key
role
membranebound
dpp
iv
play
tcellmedi
immun
respons
cytokin
product
enzym
analyz
sever
autoimmun
diseas
rheumatoid
arthriti
system
lupu
erythematosu
dpp
iv
receptor
streptokinas
sk
rheumatoid
synovi
fibroblast
via
ltsrpa
amino
acid
sequenc
bind
sk
bacteri
protein
dpp
iv
result
appear
antisk
antidpp
iv
autoantibodi
patient
myocardi
infarct
treat
sk
base
observ
potent
immunogen
sk
patient
autoimmun
diseas
sk
could
bind
dpp
iv
induc
signific
level
antisk
antidpp
iv
antibodi
product
recent
detect
antibodi
nine
differ
neuronspecif
antigen
sera
autist
children
antibodi
bound
differ
encephalitogen
molecul
ie
milk
butyrophilin
chlamydia
pneumonia
streptococcu
protein
well
neurolog
antigen
chlamydia
streptococci
mani
infecti
agent
produc
molecul
call
superantigen
heat
shock
protein
hsp
modul
host
immun
function
bacteri
superantigen
transactiv
endogen
superantigen
stress
stimuli
includ
exposur
oxid
radic
heavi
metal
anoxia
infect
induct
endogen
superantigen
infect
might
exert
profound
impact
immun
respons
nudg
autoimmun
condit
given
observ
sinc
hsp
potent
immunogen
protein
hypothes
hsp
dietari
peptid
may
bind
dpp
iv
peptidas
induc
autoantibodi
product
assess
hypothesi
group
healthi
control
subject
compar
patient
autism
ii
mix
connect
tissu
diseas
data
suggest
potenti
role
dietari
peptid
process
definit
relationship
infect
dietari
peptid
autism
establish
present
studi
design
identifi
epitop
hsp
gliadin
could
bind
aminopeptidas
tissu
lymphocyt
receptor
result
autoantibodi
product
possibl
autoimmun
autism
patient
blood
sampl
subject
male
femal
year
age
mean
year
diagnosi
autism
sent
differ
clinician
laboratori
immunolog
examin
clinic
diagnosi
autism
made
accord
dsmiiir
criteria
establish
american
psychiatr
associ
washington
dc
well
development
pediatrician
pediatr
neurologist
andor
licens
psychologist
sampl
exclud
medic
histori
includ
head
injuri
evid
glioma
failur
thrive
known
factor
may
contribut
abnorm
develop
blood
sampl
patient
confirm
diagnosi
mix
connect
tissu
diseas
femal
male
year
age
antinuclear
antibodi
ana
titer
greater
smrnp
speckl
pattern
chromosom
neg
select
collect
sera
preserv
comparison
serum
sampl
healthi
control
children
age
year
adult
age
year
neg
ana
titer
known
autoimmun
diseas
includ
test
request
properli
document
kept
confidenti
file
person
gave
inform
consent
allow
inclus
data
report
without
disclosur
ident
peptid
gliadin
peptid
gliadin
peptid
qqlpqpqqpqqsfpqq
qpf
chlamydia
trachomati
peptid
lkqiaahagkegaiifq
qvm
highperform
liquid
chromatographi
grade
synthes
biosynthesi
inc
lewisvil
tex
ii
protein
dpp
iv
aminopeptidas
aminopeptidas
n
sk
lipopolysaccharid
lp
human
serum
albumin
hsa
purchas
sigma
st
loui
mo
iii
antibodi
antibodi
dpp
iv
dpp
aminopeptidas
n
sk
gliadin
peptid
prepar
rabbit
accord
standard
protocol
cocalico
biolog
inc
reamstown
pa
polyclon
antibodi
purifi
affin
chromatographi
protein
asepharos
elisa
enzymelink
immunosorb
assay
elisa
use
test
antibodi
differ
antigen
sera
patient
autism
autoimmun
diseas
control
subject
antigen
peptid
dissolv
methanol
concentr
mgml
dilut
carbonatebicarbon
buffer
ph
l
ad
well
polystyren
flatbottom
elisa
plate
plate
incub
overnight
wash
three
time
l
trisbuff
salin
tb
contain
tween
ph
nonspecif
bind
immunoglobulin
ig
prevent
ad
mixtur
bovin
serum
albumin
bsa
gelatin
tb
incub
mixtur
h
room
temperatur
overnight
plate
wash
describ
serum
sampl
dilut
hsa
tb
contain
igg
fc
fragment
avoid
reactiv
specif
antibodi
rheumatoid
factor
ad
duplic
well
incub
h
room
temperatur
sera
patient
autoimmun
disord
known
high
titer
igg
igm
iga
dpp
iv
gliadin
hsp
peptid
use
dilut
construct
standard
curv
rule
nonspecif
antibodi
activ
plate
wash
alkalin
phosphataseconjug
goat
antihuman
igg
igm
iga
f
fragment
kpi
gaithersburg
md
optim
dilut
hsatb
ad
well
plate
incub
addit
h
room
temperatur
wash
five
time
tbstween
buffer
enzym
reaction
start
ad
l
paranitrophenylphosph
ml
diethanolamin
buffer
mgml
contain
mm
mgcl
sodium
azid
ph
reaction
stop
min
later
l
n
naoh
optic
densiti
read
nm
od
microtit
reader
detect
nonspecif
bind
sever
control
well
contain
reagent
except
human
serum
well
coat
differ
tissu
antigen
reagent
use
coeffici
intraassay
interassay
variat
igg
igm
iga
dpp
iv
dpp
less
calcul
optim
serum
dilut
two
sera
healthi
control
low
level
antibodi
dpp
iv
gliadin
hsp
peptid
two
sera
patient
autoimmun
diseas
two
sera
autist
children
known
high
titer
antibodi
use
construct
standard
control
curv
sera
dilut
dilut
standard
curv
sampl
autoimmun
diseas
autism
linear
od
antibodi
antigen
detect
healthi
control
sera
od
henc
antibodi
detect
autist
autoimmun
sera
perform
dilut
appropri
buffer
absorpt
sera
specif
nonspecif
antigen
peptid
three
autist
patient
sera
contain
high
level
igg
iga
antibodi
dpp
iv
od
elisa
three
control
sera
insignific
level
igg
iga
antibodi
use
inhibit
studi
differ
test
tube
ml
serum
sampl
preincub
l
contain
g
either
hsa
lp
dpp
iv
dpp
gliadin
peptid
mix
tube
kept
h
water
bath
follow
incub
centrifug
g
min
supernat
use
measur
antibodi
level
compar
elisa
od
unabsorb
absorb
sera
nonspecif
specif
antigen
possibl
bind
sk
gliadin
peptid
dpp
iv
sinc
interact
dpp
iv
sk
shown
associ
sk
antidpp
iv
autoantibodi
sought
possibl
bind
peptid
dpp
iv
dpp
seri
elisa
experi
carri
establish
bind
specif
peptid
dpp
iv
peptidas
plate
coat
dpp
iv
first
bsa
hsa
inhibit
nonspecif
bind
sk
gliadin
ad
demonstr
bind
sk
gliadin
dpp
iv
purifi
rabbit
antidpp
iv
antisk
antigliadin
combin
antidpp
ivantisk
antidpp
iv
antisk
antidpp
iv
antigliadin
antidpp
iv
antihsp
antibodi
ad
differ
well
coat
either
bsa
hsa
dpp
iv
hsa
dpp
iv
sk
dpp
iv
gliadin
dpp
iv
see
tabl
plate
incub
h
wash
five
time
remov
unbound
compet
antigen
purifi
rabbit
antidpp
iv
sk
gliadin
peptid
ad
differ
well
concentr
bound
rabbit
antibodi
determin
describ
alkalin
phosphataselabel
antirabbit
igg
antihuman
ig
complex
dpp
iv
dpp
iv
enzym
activ
serum
sampl
level
complex
dpp
iv
measur
control
sera
dpp
iv
antibodi
sera
autist
children
high
level
igg
antidpp
iv
antibodi
level
determin
ad
l
control
patient
serum
ml
serum
diluent
buffer
plate
coat
monoclon
antidpp
iv
antibodi
incub
h
plate
wash
incub
antihuman
igg
h
follow
incub
substrat
measur
color
develop
nm
dpp
iv
enzym
activ
measur
mm
glypropnitroanilid
reaction
mixtur
l
contain
l
serum
sampl
mm
trishcl
ph
hydrolysi
substrat
monitor
nm
statist
analysi
gener
consider
main
object
data
analysi
examin
differ
level
igg
igm
iga
antibodi
among
four
group
children
condit
adult
condit
children
autism
adult
patient
autoimmun
diseas
antidpp
iv
autoantibodi
level
antidpp
antibodi
level
antiaminopeptidas
n
autoantibodi
level
antigliadin
peptid
autoantibodi
level
igg
igm
iga
consid
three
depend
variabl
one
factor
variabl
divid
sampl
four
group
mention
gener
linear
model
glm
window
advanc
option
spss
inc
chicago
ill
use
studi
use
hotel
trace
exact
f
statist
provid
addit
post
hoc
test
signific
differ
test
perform
glm
multivari
procedur
provid
analysi
varianc
multipl
depend
variabl
one
factor
variabl
factor
variabl
divid
popul
variou
group
joint
distribut
depend
variabl
ii
bonferroni
tukey
test
signific
bonferroni
tukey
signific
differ
test
commonli
use
bonferroni
test
base
student
statist
adjust
observ
signific
level
fact
multipl
comparison
made
post
hoc
analysi
bonferroni
tukey
honestli
signific
differ
test
perform
result
remark
similar
three
method
therefor
result
test
report
statist
evalu
tabl
show
hotel
trace
valu
exact
f
statist
hypothesi
degre
freedom
glm
multivari
test
result
glm
indic
overal
except
signific
differ
exist
group
control
children
control
adult
autism
autoimmun
diseas
patient
depend
variabl
dpp
iv
dpp
gliadin
peptid
p
antidpp
iv
autoantibodi
level
control
children
autism
patient
autoimmun
diseas
use
elisa
sera
healthi
subject
autist
children
patient
mix
connect
tissu
diseas
analyz
igg
igm
iga
antibodi
dpp
iv
result
express
mean
od
sd
summar
autist
children
patient
autoimmun
diseas
p
tabl
level
igm
antidpp
iv
healthi
control
patient
autism
autoimmun
diseas
also
shown
fig
serum
igm
antibodi
significantli
higher
patient
control
mean
sd
valu
control
patient
autism
patient
autoimmun
diseas
p
fig
od
cutoff
point
use
control
versu
patient
autism
patient
autoimmun
condit
show
elev
igm
antibodi
level
p
tabl
likewis
iga
antibodi
level
dpp
iv
examin
three
group
individu
mean
sd
data
depict
fig
show
signific
differ
control
patient
group
mean
sd
iga
antibodi
level
control
patient
autism
autoimmun
condit
p
percent
elev
serum
iga
antidpp
iv
antibodi
od
valu
greater
significantli
higher
patient
autism
autoimmun
diseas
control
tabl
analysi
antidpp
igg
igm
iga
level
control
patient
autism
autoimmun
diseas
show
signific
differ
antibodi
valu
percent
elev
antibodi
dpp
fig
mean
sd
od
valu
control
patient
autism
patient
autoimmun
diseas
p
fig
post
hoc
multivari
comparison
dpp
tabl
reveal
control
group
igg
igm
iga
statist
ident
igg
iga
autism
autoimmun
group
also
alik
howev
igm
signific
differ
autoimmun
autism
group
detect
overal
autism
autoimmun
group
statist
differ
compar
control
group
percent
elev
igg
igm
iga
antibodi
control
autism
group
autoimmun
group
tabl
antiaminopeptidas
n
autoantibodi
level
control
children
autism
patient
autoimmun
diseas
similar
analysi
dpp
iv
dpp
data
level
igg
igm
iga
antibodi
significantli
higher
patient
autism
autoimmun
diseas
control
fig
comparison
dpp
iv
dpp
percent
elev
autoantibodi
group
patient
significantli
lower
igm
p
igg
iga
p
tabl
result
tabl
show
igg
iga
similar
control
group
autoimmun
autism
alik
yet
signific
differ
detect
control
group
autism
autoimmun
group
accord
data
igm
differ
four
group
detect
antigliadin
peptid
autoantibodi
level
control
children
autism
patient
autoimmun
diseas
concomit
increas
igg
igm
iga
dpp
iv
dpp
observ
statist
signific
increas
antigliadin
antibodi
patient
sera
antibodi
control
patient
autism
autoimmun
diseas
p
fig
tabl
result
gliadin
peptid
tabl
show
igm
iga
control
group
gliadin
peptid
statist
alik
similarli
autism
autoimmun
group
ident
yet
control
group
differ
compar
autism
autoimmun
group
final
result
tabl
show
iga
control
group
statist
differ
autoimmun
autism
group
howev
igg
similar
autoimmun
group
group
au
tism
control
detect
autism
control
group
similar
differ
autoimmun
group
igm
differ
autism
group
control
adult
observ
autism
group
statist
differ
compar
control
children
valu
well
percent
elev
igg
igm
iga
antibodi
gliadin
present
tabl
examin
possibl
involv
gliadin
peptid
product
autoantibodi
differ
peptidas
calcul
simultan
elev
antibodi
patient
sera
made
see
fig
sera
children
autism
high
igg
igm
iga
dpp
iv
dpp
simultan
elev
antibodi
gliadin
peptid
fig
correl
igg
igm
iga
antibodi
dpp
iv
dpp
gliadin
peptid
sera
patient
autoimmun
diseas
fig
concomit
detect
antibodi
five
test
antigen
dpp
iv
dpp
gliadin
peptid
measur
sera
children
autism
versu
sera
respect
patient
autoimmun
diseas
simultan
elev
iga
igg
igm
antibodi
level
test
antigen
absorpt
antidpp
iv
antibodi
dpp
iv
dpp
gliadin
peptid
hsa
lp
examin
whether
antibodi
dpp
iv
specif
crossreact
perform
absorpt
analysi
use
nonspecif
antigen
lp
hsa
specif
antigen
dpp
iv
antigen
dpp
gliadin
antibodi
detect
simultan
result
summar
tabl
show
dpp
iv
dpp
significantli
absorb
igg
iga
antibodi
specif
antigen
dpp
iv
use
expect
exampl
antidpp
ivposit
sera
absorb
dpp
iv
ddp
gliadin
hsa
lp
tabl
inhibit
antibodi
differ
antigen
vari
among
sampl
igg
versu
iga
possibl
bind
sk
gliadin
peptid
dpp
iv
demonstr
sk
gliadin
bind
dpp
iv
polyclon
antibodi
ad
differ
well
rabbit
antidpp
iv
reaction
well
coat
dpp
iv
result
elisa
od
addit
sk
gliadin
caus
inhibit
dpp
iv
antidpp
iv
elisa
valu
furthermor
well
coat
dpp
iv
sk
dpp
iv
gliadin
dpp
iv
rabbit
antibodi
sk
gliadin
capabl
react
specif
antigen
ad
dpp
iv
result
od
sd
background
tabl
elisa
od
indic
bind
sk
gliadin
dpp
iv
similar
result
obtain
instead
dpp
iv
plate
dpp
use
data
shown
detect
complex
dpp
iv
dpp
iv
enzym
activ
mean
sd
complex
igg
dpp
iv
control
patient
autism
p
bind
antidpp
iv
dpp
iv
serum
may
result
lower
activ
dpp
iv
fact
dpp
iv
activ
measur
specif
substrat
od
specimen
neg
dpp
iv
antibodi
march
guest
http
cviasmorg
specimen
high
level
dpp
iv
antibodi
overal
comparison
sera
without
dpp
iv
antibodi
od
sampl
high
level
dpp
iv
antibodi
lower
p
immunolog
research
suggest
autoimmun
pathogen
factor
autism
possibl
autoimmun
autism
strengthen
earlier
investig
demonstr
antibodi
nine
differ
neuronspecif
antigen
crossreact
protein
peptid
milk
c
pneumonia
streptococcu
group
studi
suggest
role
milk
protein
bacteri
antigen
pathogenesi
autist
behavior
base
find
earlier
report
elev
antidpp
iv
antisk
antibodi
rheumatoid
arthriti
system
lupu
erythematosu
patient
myocardi
infarct
first
examin
exist
dpp
iv
autoantibodi
blood
sampl
children
autism
compar
level
patient
mix
connect
tissu
diseas
fig
tabl
second
ask
whether
antibodi
peptidas
dpp
detect
sera
patient
autoimmun
diseas
children
autism
surpris
found
almost
similar
level
igg
igm
iga
antibodi
dpp
patient
mix
connect
tissu
diseas
autism
control
fig
antibodi
dpp
iv
appear
specif
sinc
absorpt
studi
dpp
iv
capabl
reduc
significantli
level
igg
iga
antidpp
iv
antibodi
highli
posit
sera
dpp
reduc
level
antibodi
less
signific
degre
tabl
partial
absorpt
antidpp
iv
antibodi
dpp
may
indic
product
antidpp
autoantibodi
due
differ
mechan
action
due
crossreact
dpp
iv
dpp
base
find
hypothes
infecti
agent
superantigen
includ
sk
dietari
protein
gliadin
peptid
individu
predispos
hla
molecul
may
bind
differ
aminopeptidas
induc
autoantibodi
peptid
tissu
antigen
test
hypothesi
base
gliadin
peptid
bind
transglutaminas
brush
border
celiac
diseas
patient
measur
antigliadin
peptid
antibodi
blood
sampl
children
autism
patient
autoimmun
diseas
data
present
fig
tabl
show
similar
antidpp
iv
antidpp
antibodi
level
signific
number
autist
autoimmun
sera
exhibit
antigliadin
peptid
antibodi
ask
follow
question
percentag
autism
autoimmun
sera
posit
antibodi
dpp
iv
dpp
also
concomit
elev
gliadin
antibodi
answer
depict
fig
patient
autism
autoimmun
diseas
elev
dpp
iv
dpp
antibodi
also
antigliadin
antibodi
sinc
inhibit
studi
tabl
gliadin
hsp
capabl
reduc
level
dpp
iv
antibodi
mean
antigen
similar
gliadin
hsp
dpp
iv
similar
sk
bind
dpp
iv
postul
gliadin
peptid
bind
aminopeptidas
respons
antigliadin
antihsp
antidpp
iv
antidpp
autoantibodi
product
analysi
result
show
autoimmun
sera
simultan
elev
igg
igm
iga
antibodi
test
antigen
autist
sera
elev
antibodi
dpp
iv
dpp
gliadin
high
level
iga
product
children
autism
three
peptidas
gliadin
hsp
peptid
indic
reaction
molecul
tissu
peptidas
inde
signific
differ
test
employ
four
group
overal
autism
autoimmun
group
similar
level
igg
igm
iga
antibodi
significantli
differ
control
tabl
result
support
strong
evid
bind
gliadin
hsp
peptid
aminopeptidas
similar
antibodi
respons
membran
peptidas
sk
hsp
gliadin
peptid
children
autism
patient
autoimmun
diseas
evid
suggest
autoimmun
autism
use
rabbit
antidpp
iv
antisk
antigliadin
antibodi
seri
elisa
experi
carri
demonstr
bind
specif
sk
gliadin
hsp
peptid
dpp
ivcoat
plate
bind
sk
gliadin
dpp
iv
result
inhibit
rabbit
antibodi
bind
dpp
iv
addit
introduct
rabbit
antisk
antigliadin
antihsp
antibodi
plate
coat
dpp
iv
first
sk
gliadin
hsp
result
enhanc
od
background
result
support
bind
sk
gliadin
hsp
dpp
iv
vitro
possibl
vivo
tabl
result
conclud
bind
bacteri
superantigen
dietari
peptid
dpp
iv
dpp
respons
autoantibodi
product
children
autism
patient
autoimmun
diseas
take
consider
short
halfliv
igg
igm
iga
circul
find
suggest
sk
hsp
gliadin
peptid
persist
long
period
host
tissu
persist
sk
hsp
gliadin
peptid
circul
result
autoantibodi
well
reduct
serum
peptidas
activ
increas
complex
format
peptidas
respect
antibodi
product
dpp
iv
autoantibodi
reduc
level
circul
dpp
iv
children
autism
perhap
part
repair
mechan
nonspecif
coliti
ileallymphoidnodular
hyperplasia
report
children
pervas
development
disord
contradictori
effect
immun
system
explain
bimod
action
dpp
iv
immun
function
final
virtu
exopeptidas
activ
forget
dpp
iv
play
key
regulatori
role
metabol
peptid
thu
inactiv
peptidas
autoantibodi
may
result
accumul
dietari
peptid
gluteomorphin
casomorphin
gut
circul
result
possibl
neuroimmun
dysregul
molecular
mimicri
peptid
human
tissu
antigen
myosin
cerebellar
antigen
may
result
sensit
crossreact
cell
could
mediat
demyelin
process
activ
cell
may
stimul
b
cell
produc
specif
antibodi
direct
nerv
cell
compon
recruit
macrophag
effector
cell
combin
humor
cellular
factor
includ
cytokin
may
therefor
particip
caus
diseas
furthermor
bind
antibodi
lymphocyt
may
interfer
major
histocompat
complex
class
antigen
present
cytokin
produc
shown
inhibit
antidpp
iv
antibodi
bind
dpp
iv
bsa
hsa
sk
gliadin
bind
sk
gliadin
dpp
iv
specif
nonspecif
rabbit
antibodi
note
alkalin
phosphataseconjug
goat
antirabbit
igg
result
posit
b
bg
background
ns
signific
tion
inhibit
autoreact
lymphocyt
apoptosi
autoimmun
whether
autoantibodi
bind
tissu
enzym
lymphocyt
receptor
caus
symptom
patient
mix
connect
tissu
diseas
autism
remain
determin
word
possibl
make
strong
distinct
induct
autoimmun
etiolog
autoimmun
diseas
inject
label
gliadin
hsp
peptid
anim
model
demonstr
increas
level
antibodi
blood
induct
abnorm
metabol
neuropeptid
brain
support
hypothesi
identif
pathogen
peptid
oral
administr
suggest
patient
celiac
diseas
patient
idiopath
dilat
cardiomyopathi
may
help
design
oral
toler
immun
suppress
strategi
patient
autism
autoimmun
diseas
inde
oral
toler
induc
mycobacterium
tuberculosi
prove
novel
mean
suppress
autoimmun
atherogenesi
